(ENZY) Enzymatica publ - Performance 3.6% in 12m
Compare ENZY with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-61.61%
#117 in Group
Rel. Strength
67.55%
#2583 in Universe
Total Return 12m
3.64%
#48 in Group
Total Return 5y
-64.06%
#106 in Group
P/E -
(?) Percentile in Group
P/E Forward 66.7
85th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -9.33%
(?) Percentile in Group
12m Total Return: ENZY (3.6%) vs XLV (-4.1%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
1.26% | 181% | 420% | 58.1 | 44.4 | 0.61 | 48.6% | 9.63% |
| LLY NYSE Eli Lilly |
3.47% | -2.41% | 404% | 67 | 36.6 | 1.33 | 58.2% | 18.9% |
| NVS NYSE Novartis |
8.01% | 14.6% | 64.6% | 17.9 | 13.9 | 1.36 | 8.40% | 9.2% |
| NOVN SW Novartis |
2.79% | 4.23% | 40.3% | 19.3 | 13.9 | 1.32 | 9.80% | 11.2% |
| SOBI ST Swedish Orphan Biovitrum |
12% | 5.01% | 48.3% | 25.6 | 20.9 | 1.61 | 16.1% | 29% |
| SAN PA Sanofi |
-1.52% | 2.67% | 20.4% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
| IPN PA Ipsen |
1.81% | -12.6% | 57.8% | 23.3 | 9.65 | 0.69 | -6.40% | -6.33% |
| SUPN NASDAQ Supernus Pharmaceuticals |
2.94% | 0.77% | 35.3% | 24.6 | 20.2 | 1.47 | -5.90% | -17% |
Performance Comparison: ENZY vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for ENZY
| Total Return (including Dividends) | ENZY | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -18.53% | 0.87% | 13.81% |
| 3 Months | 79.04% | -7.96% | -6.30% |
| 12 Months | 3.64% | -4.06% | 10.65% |
| 5 Years | -64.06% | 43.49% | 107.77% |
| Trend Score (consistency of price movement) | ENZY | XLV | S&P 500 |
| 1 Month | -75.5% | -8.1% | 83% |
| 3 Months | 48.1% | -75.3% | -75.3% |
| 12 Months | -4.10% | -28.8% | 50.1% |
| 5 Years | -89.9% | 89.7% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #175 | -19.2% | -28.4% |
| 3 Month | #3 | 94.5% | 91.1% |
| 12 Month | #48 | 8.03% | -6.33% |
| 5 Years | #109 | -75.0% | -82.7% |
FAQs
Does ENZY Enzymatica publ outperforms the market?
Yes,
over the last 12 months ENZY made 3.64%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.06%.
Over the last 3 months ENZY made 79.04%, while XLV made -7.96%.
Over the last 3 months ENZY made 79.04%, while XLV made -7.96%.
Performance Comparison ENZY vs Indeces and Sectors
ENZY vs. Indices ENZY is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.73% | -32.3% | 72.0% | -7.01% |
| US NASDAQ 100 | QQQ | -4.92% | -35.9% | 71.8% | -8.0% |
| US Dow Jones Industrial 30 | DIA | -5.14% | -28.5% | 72.3% | -4.07% |
| German DAX 40 | DAX | -4.71% | -33.5% | 45.7% | -22.1% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6.91% | -30.4% | 71.2% | -3.73% |
| Hongkong Hang Seng | HSI | -7.90% | -38.5% | 63.6% | -10.0% |
| India NIFTY 50 | INDA | 0.19% | -23.4% | 71.5% | 3.85% |
| Brasil Bovespa | EWZ | -5.78% | -35.8% | 63.3% | 12.0% |
ENZY vs. Sectors ENZY is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -5.37% | -31.9% | 64.9% | -17.9% |
| Consumer Discretionary | XLY | -5.11% | -32.8% | 73.0% | -10.6% |
| Consumer Staples | XLP | -3.87% | -25.1% | 65.1% | -5.48% |
| Energy | XLE | -4.55% | -25.3% | 78.6% | 13.1% |
| Financial | XLF | -5.83% | -32.1% | 64.9% | -18.8% |
| Health Care | XLV | -1.72% | -19.4% | 77.0% | 7.70% |
| Industrial | XLI | -6.42% | -35.4% | 70.6% | -7.35% |
| Materials | XLB | -4.53% | -32.1% | 76.9% | 8.87% |
| Real Estate | XLRE | -3.41% | -30.1% | 71.2% | -11.8% |
| Technology | XLK | -5.81% | -39.8% | 74.9% | -3.46% |
| Utilities | XLU | -4.78% | -28.1% | 64.3% | -13.8% |
| Aerospace & Defense | XAR | -6.71% | -39.7% | 60.5% | -23.7% |
| Biotech | XBI | 1.86% | -30.3% | 92.1% | 15.9% |
| Homebuilder | XHB | -5.20% | -30.0% | 85.2% | 11.2% |
| Retail | XRT | -6.63% | -33.2% | 76.2% | 5.12% |